Li Yu, Chen Dong-Ning, Cui Jing, Xin Zhong, Yang Guang-Ran, Niu Ming-Jia, Yang Jin-Kui
Physical Examination Department, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.
Department of Endocrinology, Beijing Key Laboratory of Diabetes Research and Care, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.
BMC Endocr Disord. 2016 Nov 6;16(1):57. doi: 10.1186/s12902-016-0137-3.
Subclinical hypothyroidism, commonly caused by Hashimoto thyroiditis (HT), is a risk factor for cardiovascular diseases. This disorder is defined as merely having elevated serum thyroid stimulating hormone (TSH) levels. However, the upper limit of reference range for TSH is debated recently. This study was to determine the cutoff value for the upper normal limit of TSH in a cohort using the prevalence of Hashimoto thyroiditis as "gold" calibration standard.
The research population was medical staff of 2856 individuals who took part in health examination annually. Serum free triiodothyronine (FT3), free thyroxine (FT4), TSH, thyroid peroxidase antibody (TPAb), thyroglobulin antibody (TGAb) and other biochemistry parameters were tested. Meanwhile, thyroid ultrasound examination was performed. The diagnosis of HT was based on presence of thyroid antibodies (TPAb and TGAb) and abnormalities of thyroid ultrasound examination. We used two different methods to estimate the cutoff point of TSH based on the prevalence of HT.
Joinpoint regression showed the prevalence of HT increased significantly at the ninth decile of TSH value corresponding to 2.9 mU/L. ROC curve showed a TSH cutoff value of 2.6 mU/L with the maximized sensitivity and specificity in identifying HT. Using the newly defined cutoff value of TSH can detect patients with hyperlipidemia more efficiently, which may indicate our approach to define the upper limit of TSH can make more sense from the clinical point of view.
A significant increase in the prevalence of HT occurred among individuals with a TSH of 2.6-2.9 mU/L made it possible to determine the cutoff value of normal upper limit of TSH.
亚临床甲状腺功能减退通常由桥本甲状腺炎(HT)引起,是心血管疾病的一个危险因素。这种疾病仅被定义为血清促甲状腺激素(TSH)水平升高。然而,TSH参考范围的上限最近存在争议。本研究旨在以桥本甲状腺炎的患病率作为“金”校准标准,确定队列中TSH正常上限的临界值。
研究人群为2856名每年参加健康体检的医务人员。检测血清游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、TSH、甲状腺过氧化物酶抗体(TPAb)、甲状腺球蛋白抗体(TGAb)及其他生化参数。同时进行甲状腺超声检查。HT的诊断基于甲状腺抗体(TPAb和TGAb)的存在及甲状腺超声检查异常。我们基于HT的患病率,采用两种不同方法估计TSH的临界值。
连接点回归显示,在TSH值对应2.9 mU/L的第九十分位数处,HT的患病率显著增加。ROC曲线显示,TSH临界值为2.6 mU/L时,在识别HT方面具有最大的敏感性和特异性。使用新定义的TSH临界值能更有效地检测高脂血症患者,这可能表明我们定义TSH上限的方法从临床角度更有意义。
TSH为2.6 - 2.9 mU/L的个体中HT患病率显著增加,这使得确定TSH正常上限的临界值成为可能。